A Study of Calderasib (MK-1084) Human Absorption, Distribution, Metabolism, and Excretion in Healthy Adult Participants (MK-1084-006)
Clinical trial NCT06687759 · COMPLETED
Trial details
- NCT number
- NCT06687759
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-26
- Primary completion
- 2024-08-07
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.